---------- > From: Robert Pyle <pyle@smtpgw.kfshrc.edu.sa> > To: Cytometry Mailing List <cytometry@flowcyt.cyto.purdue.edu> > Subject: anti human OX40 antibody > Date: Sunday, August 17, 1997 9:31 AM > > > > We are interested in looking at the feasibility of assaying for OX40 expression > in our post transplant patients who have a transplant crisis. We wonder if it > might be an aid in detecting the difference in cyclosporin toxicity or immune > transplant rejection. Has anyone else looked at this? > > Also, the one source that I have thus far located for the antibody has indicated > that their product (Pharmingen) is suitable for fixed, paraffin embedded tissue > sections but does not mention suitability or unsuitability of the antibody for > flow cytometric procedures. Has anyone used the Pharmingen OX40 antibody for > floe cytometry? What are your experiences? > Robert, were using the anti-OX 40 antibody (CD134) from Pharminigen for flow analysis of peripheral blood in patients post-allo BMT. We have the PE clone. Expression is on the dim side. Not sure of any work in solid organ setting. The data looks very interesting in allogeneic bone marrow recipients. You might want to take a look at a recent paper that appeared in Blood from Richard Maziarz lab at Oregon UHC.
This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:50:02 EST